Cite
APA Citation
Denton, C., Bloom, B., Dgetluck, N., White, B., & Spiera, R. (n.d.). aB0568 BASELINE EUROPEAN PATIENT DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN A PHASE 3 STUDY OF SAFETY AND EFFICACY OF LENABASUM, A CB2 AGONIST, IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS. Annals of the rheumatic diseases, 79, 1580–1581. http://access.bl.uk/ark:/81055/vdc_100144711856.0x000046